Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
P02656 | Apolipoprotein C-III | ||
P02671 | Fibrinogen alpha chain | ||
P02675 | Fibrinogen beta chain | ||
P02724 | Glycophorin-A | ||
P02749 | Beta-2-glycoprotein 1 | ||
P02750 | Leucine-rich alpha-2-glycoprotein | ||
P02751 | Fibronectin | ||
P02765 | Alpha-2-HS-glycoprotein | ||
P02768 | Albumin | ||
P02771 | Alpha-fetoprotein |
Pathway Name | Organism |
---|---|
Ficolins bind to repetitive carbohydrate structures on the target cell surface | Sus scrofa |
Initial triggering of complement | Mus musculus |
Initial triggering of complement | Gallus gallus |
Initial triggering of complement | Xenopus tropicalis |
Initial triggering of complement | Sus scrofa |
Initial triggering of complement | Bos taurus |
Initial triggering of complement | Canis familiaris |
Initial triggering of complement | Rattus norvegicus |
Initial triggering of complement | Homo sapiens |
Lectin pathway of complement activation | Bos taurus |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
23762286 | CLEC4F Is an Inducible C-Type Lectin in F4/80-Positive Cells and Is Involved in Alpha-Galactosylceramide Presentation in Liver | Yang CY | 2013 Jun 06 |
|
23744646 | MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion | van Vliet SJ | 2013 Jun 06 |
|
23828381 | The level of anti-(GalNAc beta) and anti-para-Forssman disaccharide IgG antibodies in patients with gastrointestinal cancer: relation to survival | Smorodin EP | 2013 Jun |
|
23873333 | Neuroprotective effect of 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside against sodium nitroprusside-induced neurotoxicity in HT22 cells | Chen X | 2013 Jul 20 |
|
23692076 | Selection ofEscherichia coliHeat-Labile Toxin (LT) Inhibitors Using Both the GM1-ELISA and the cAMP Vero Cell Assay | Verhelst R | 2013 Jul |
|
23184955 | A Single N-Acetylgalactosamine Residue at Threonine 106 Modifies the Dynamics and Structure of Interferon α2a around the Glycosylation Site | Ghasriani H | 2013 Jan 04 |
|
23398317 | Defective immunoglobulin A (<scp>IgA</scp>) glycosylation and <scp>IgA</scp> deposits in patients with <scp>IgA</scp> nephropathy | Kolka R | 2013 Feb 11 |
|
24131475 | <scp>N</scp>‐acetylgalactosamine exposure of serum <scp>IgA1</scp> was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of <scp>IgA</scp> nephropathy patients | Xu L | 2013 Dec 17 |
|
24335571 | Extending the Glucosyl Ceramide Cassette Approach: Application in the Total Synthesis of Ganglioside GalNAc-GM1b | Konishi M | 2013 Dec 10 |
|
24321012 | Avocado/soybean unsaponifiables: a novel regulator of cutaneous wound healing, modelling and remodelling | Oryan A | 2013 Dec 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025